BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25840370)

  • 1. The cis conformation of proline leads to weaker binding of a p53 peptide to MDM2 compared to trans.
    Zhan YA; Ytreberg FM
    Arch Biochem Biophys; 2015 Jun; 575():22-9. PubMed ID: 25840370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct observations of conformational distributions of intrinsically disordered p53 peptides using UV Raman and explicit solvent simulations.
    Xiong K; Zwier MC; Myshakina NS; Burger VM; Asher SA; Chong LT
    J Phys Chem A; 2011 Sep; 115(34):9520-7. PubMed ID: 21528875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a novel MDM2 binding peptide based on the p53 family.
    Madhumalar A; Lee HJ; Brown CJ; Lane D; Verma C
    Cell Cycle; 2009 Sep; 8(17):2828-36. PubMed ID: 19713735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Does the Recently Discovered Peptide MIP Exhibit Much Higher Binding Affinity than an Anticancer Protein p53 for an Oncoprotein MDM2?
    Yamada T; Hayashi T; Hikiri S; Kobayashi N; Yanagawa H; Ikeguchi M; Katahira M; Nagata T; Kinoshita M
    J Chem Inf Model; 2019 Aug; 59(8):3533-3544. PubMed ID: 31282659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction.
    Ciemny MP; Debinski A; Paczkowska M; Kolinski A; Kurcinski M; Kmiecik S
    Sci Rep; 2016 Dec; 6():37532. PubMed ID: 27905468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsecond simulations of mdm2 and its complex with p53 yield insight into force field accuracy and conformational dynamics.
    Pantelopulos GA; Mukherjee S; Voelz VA
    Proteins; 2015 Sep; 83(9):1665-76. PubMed ID: 26138282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings.
    Chen J; Wang J; Zhu W; Li G
    J Comput Aided Mol Des; 2013 Nov; 27(11):965-74. PubMed ID: 24264557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging Microscopic and Macroscopic Mechanisms of p53-MDM2 Binding with Kinetic Network Models.
    Zhou G; Pantelopulos GA; Mukherjee S; Voelz VA
    Biophys J; 2017 Aug; 113(4):785-793. PubMed ID: 28834715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Atomistic Simulation of Pathways and Calculation of Rate Constants for a Protein-Peptide Binding Process: Application to the MDM2 Protein and an Intrinsically Disordered p53 Peptide.
    Zwier MC; Pratt AJ; Adelman JL; Kaus JW; Zuckerman DM; Chong LT
    J Phys Chem Lett; 2016 Sep; 7(17):3440-5. PubMed ID: 27532687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics.
    Verkhivker GM
    PLoS One; 2012; 7(7):e40897. PubMed ID: 22815859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-naturally Occurring Helical Molecules Can Interfere with p53-MDM2 and p53-MDMX Protein-Protein Interactions.
    Su A; Wang S; Sada A; Otani Y; Zhai L; Liu X; Sayama M; Ohki R; Ohwada T
    Chem Pharm Bull (Tokyo); 2019; 67(10):1139-1143. PubMed ID: 31582633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2.
    Dastidar SG; Lane DP; Verma CS
    J Am Chem Soc; 2008 Oct; 130(41):13514-5. PubMed ID: 18800837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX.
    Pazgier M; Liu M; Zou G; Yuan W; Li C; Li C; Li J; Monbo J; Zella D; Tarasov SG; Lu W
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4665-70. PubMed ID: 19255450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the origin of structural stability of single and double stapled p53 peptide analogs bound to MDM2.
    Guo Z; Streu K; Krilov G; Mohanty U
    Chem Biol Drug Des; 2014 Jun; 83(6):631-42. PubMed ID: 24418072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding Ensembles of
    Lang L; Perez A
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of cis-trans isomerization of prolyl peptides by cyclophilin.
    Hur S; Bruice TC
    J Am Chem Soc; 2002 Jun; 124(25):7303-13. PubMed ID: 12071739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the K24N mutation on the transactivation domain of p53 and its binding to murine double-minute clone 2.
    Zhan YA; Wu H; Powell AT; Daughdrill GW; Ytreberg FM
    Proteins; 2013 Oct; 81(10):1738-47. PubMed ID: 23609977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition Dynamics of p53 and MDM2: Implications for Peptide Design.
    ElSawy KM; Lane DP; Verma CS; Caves LS
    J Phys Chem B; 2016 Jan; 120(2):320-8. PubMed ID: 26701330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational changes of the p53-binding cleft of MDM2 revealed by molecular dynamics simulations.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Biopolymers; 2006 Nov; 83(4):365-73. PubMed ID: 16817233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2.
    Yadahalli S; Neira JL; Johnson CM; Tan YS; Rowling PJE; Chattopadhyay A; Verma CS; Itzhaki LS
    Sci Rep; 2019 Jan; 9(1):693. PubMed ID: 30679555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.